.rll-youtube-player .play{--wpr-bg-07f3ce24-9d15-41a1-97e5-40eac57b74bf: url('https://catchingnews.com/wp-content/plugins/wp-rocket/assets/img/youtube.png');}.perfmatters-lazy-youtube .play{--wpr-bg-71e1f054-a9ad-4e03-a19b-3e1ccf21a487: url('https://catchingnews.com/wp-content/plugins/perfmatters/img/youtube.svg');}

Tag: Metacrine

Equity Investing

Metacrine, Inc. (MTCR) stock falls around 49.87% in aftermarket – Here’s why?

Metacrine, Inc. (MTCR) experienced a decline of 49.87% in the aftermarket because the company released Interim Results for the MET642 Phase 2a Trial. However, the

Catching News are non-trivial topics and publications about how you make money and properly dispose of it. We tell about business and entrepreneurship, start-ups, success stories. We also specialize in economic news.

Tag: Metacrine

Metacrine, Inc. (MTCR) stock falls around 49.87% in aftermarket – Here’s why?

Popular Articles

Mars Mission Boosts Rocket Lab (RKLB) Stock Performance

Aldeyra (ALDX) Stock Climbs Substantially After Positive Clinical Trial Outcome

Surge In Above Food (ABVE) Stock After Announcing Strategic Acquisition

Important Links